MYBYOME formulas revolutionize the natural health approach to assisting the body manage normal microbial balance via prebiotic and probiotic influences. Utilizing the virome (phageome) component of the body’s microbiome, this “phage” product focuses exclusively on helping the body manage Pseudomonas aeruginosa, a gram negative, rod-form bacterium. It is opportunistic, causing dysbiosis and inflammation, often associated with burns, ear infections, and bladder issues. Its resilience and resistance to treatments make it a potential challenge. Because of this, phage therapy provides an exciting avenue of scientific promise.
According to research, many strains of Pseudomonas aeruginosa produce endotoxins that arrest cellular functions which can result in cellular stress and an inflammatory response. Phage can offer a unique approach to maintaining a healthy terrain.
Many opportunistic Pseudomonas may produce irritating or inflammatory compounds like Elastase or Exoenzyme in the presence of human cells which can adversely alter the function of cellular machinery. Often times this happens when a environment or terrain changes, allowing for the microbiota shift. To prevent this, and reestablish the diversity of species, phage are an increasingly important solution.
Pseudomonas aeruginosa produces infection at a wide range of pulmonary, urinary, and soft tissue sites, much like the opportunistic Enterobacteriaceae.